Rodrigo Colombo

Rodrigo Colombo

Auto-generated profile, based on publicly available information

Rodrigo Colombo

Experimental Immunology, Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in Science Immunology
Verified
Journal Article
Closed access
AVAlessandro Vacchini
Alessandro Vacchini
ACAndrew Chancellor
Andrew Chancellor
QYQinmei Yang
Qinmei Yang
RCRodrigo Colombo
Rodrigo Colombo
JSJulian Spagnuolo
Julian Spagnuolo
GLGennaro De Libero
Gennaro De Libero
MR1T cells are a recently found class of T cells that recognize antigens presented by the major histocompatibility complex-I–related molecule MR1 in the absence of microbial infection. The nature of the self-antigens that stimulate MR1T cells remains unclear, hampering our understanding of their physiological role and therapeutic potential. By combining genetic, pharmacological, and biochemical approaches, we found that carbonyl stress and changes in nucleobase metabolism in target cells promote MR1T cell activation. Stimulatory compounds formed by carbonyl adducts of nucleobases were detected within MR1 molecules produced by tumor cells, and their abundance and antigenicity were enhanced by drugs that induce carbonyl accumulation. Our data reveal carbonyl-nucleobase adducts as MR1T cell antigens. Recognizing cells under carbonyl stress allows MR1T cells to monitor cellular metabolic changes with physiological and therapeutic implications.

29 June 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ACAndrew Chancellor
Andrew Chancellor
RSRobert Alan Simmons
Robert Alan Simmons
RKRahul C. Khanolkar
Rahul C. Khanolkar
VNVladimir Nosi
Vladimir Nosi
ABAisha Beshirova
Aisha Beshirova
MLMarco Lepore
Marco Lepore
Mucosal-associated invariant T (MAIT) cells use canonical semi-invariant T cell receptors (TCR) to recognize microbial riboflavin precursors displayed by the antigen-presenting molecule MR1. The extent of MAIT TCR crossreactivity toward physiological, microbially unrelated antigens remains underexplored. We describe MAIT TCRs endowed with MR1-dependent reactivity to tumor and healthy cells in the absence of microbial metabolites. MAIT cells bearing TCRs crossreactive toward self are rare but commonly found within healthy donors and display T-helper-like functions in vitro. Experiments with MR1-tetramers loaded with distinct ligands revealed significant crossreactivity among MAIT TCRs both ex vivo and upon in vitro expansion. A canonical MAIT TCR was selected on the basis of extremely promiscuous MR1 recognition. Structural and molecular dynamic analyses associated promiscuity to unique TCRβ-chain features that were enriched within self-reactive MAIT cells of healthy individuals. Thus, self-reactive recognition of MR1 represents a functionally relevant indication of MAIT TCR crossreactivity, suggesting a potentially broader role of MAIT cells in immune homeostasis and diseases, beyond microbial immunosurveillance.